CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Passive income strategies can provide financial stability. Learn how to use index funds to create a reliable income stream.
21,140 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
With his 80th birthday approaching, Trump orchestrates high-profile appearances and a major White House event to proj...
A focused duplex hunt in St. Louis turned into an eight-unit treasure, thanks to bold moves, solid numbers, and a kna...
Pennsylvania is weighing a tax move that would extend the state's telecom gross receipts tax to digital advertising. ...
Americans donated a record 617B in 2025 despite higher living costs. Individual gifts rose, bequests surged, and bill...
Two platform leaders redefine how we shop and travel. This guide breaks down which stock—DoorDash or Uber Technologie...
When berkshire hathaway just made a surprising Alphabet bet, investors sit up and take notice. This article explains ...
Amazon stock has cooled after a strong run, but bulls argue AI investments, AWS momentum, and ad growth could fuel a ...
Papa John's approaches 2025 with a focus on digital growth, franchise economics, and international expansion. This ar...
Arm Holdings sparked a notable February rally as revenue and earnings beat expectations and AI demand sharpened. This...
Cruise stocks are among the S&P 500’s biggest decliners as Middle East tensions and higher fuel costs bite into deman...
As March rolls in, the market keeps delivering surprises. This guide highlights two prime opportunities to buy in Mar...